Original
El caso Glivec®: primer ejemplo de debate global en torno al sistema de patentes de medicamentos
The Glivec® case: the first example of a global debate on the drug patent system
Inês Moitala, Fèlix Boschb,c,
, Magí Farréa, Mariano Maddalenob, Josep-E. Bañosb
Corresponding author
a Departamento de Farmacología, Terapéutica y Toxicología, Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, España
b Departamento de Ciencias Experimentales y de la Salud, Facultad de Ciencias de la Salud y de la Vida, Universitat Pompeu Fabra, Barcelona, España
c Fundación Dr. Antonio Esteve, Barcelona, España
Read
15677
Timeswas read the article
3366
Total PDF
12311
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 124 | 43 | 167 |
| 2025 5 | 255 | 34 | 289 |
| 2025 4 | 237 | 40 | 277 |
| 2025 3 | 195 | 47 | 242 |
| 2025 2 | 249 | 29 | 278 |
| 2025 1 | 139 | 16 | 155 |
| 2024 12 | 133 | 36 | 169 |
| 2024 11 | 187 | 50 | 237 |
| 2024 10 | 147 | 53 | 200 |
| 2024 9 | 173 | 30 | 203 |
| 2024 8 | 132 | 36 | 168 |
| 2024 7 | 80 | 34 | 114 |
| 2024 6 | 114 | 21 | 135 |
| 2024 5 | 103 | 26 | 129 |
| 2024 4 | 103 | 32 | 135 |
| 2024 3 | 133 | 27 | 160 |
| 2024 2 | 88 | 43 | 131 |
| 2024 1 | 80 | 17 | 97 |
| 2023 12 | 83 | 24 | 107 |
| 2023 11 | 135 | 35 | 170 |
| 2023 10 | 99 | 17 | 116 |
| 2023 9 | 107 | 26 | 133 |
| 2023 8 | 71 | 21 | 92 |
| 2023 7 | 103 | 24 | 127 |
| 2023 6 | 139 | 18 | 157 |
| 2023 5 | 132 | 17 | 149 |
| 2023 4 | 97 | 18 | 115 |
| 2023 3 | 134 | 53 | 187 |
| 2023 2 | 133 | 16 | 149 |
| 2023 1 | 106 | 35 | 141 |
| 2022 12 | 129 | 36 | 165 |
| 2022 11 | 160 | 71 | 231 |
| 2022 10 | 126 | 59 | 185 |
| 2022 9 | 153 | 45 | 198 |
| 2022 8 | 88 | 81 | 169 |
| 2022 7 | 94 | 48 | 142 |
| 2022 6 | 110 | 44 | 154 |
| 2022 5 | 125 | 51 | 176 |
| 2022 4 | 143 | 46 | 189 |
| 2022 3 | 152 | 59 | 211 |
| 2022 2 | 153 | 54 | 207 |
| 2022 1 | 163 | 51 | 214 |
| 2021 12 | 102 | 52 | 154 |
| 2021 11 | 118 | 75 | 193 |
| 2021 10 | 100 | 71 | 171 |
| 2021 9 | 100 | 51 | 151 |
| 2021 8 | 80 | 59 | 139 |
| 2021 7 | 71 | 31 | 102 |
| 2021 6 | 86 | 33 | 119 |
| 2021 5 | 207 | 59 | 266 |
| 2021 4 | 148 | 60 | 208 |
| 2021 3 | 136 | 26 | 162 |
| 2021 2 | 43 | 20 | 63 |
| 2021 1 | 75 | 40 | 115 |
| 2020 12 | 75 | 30 | 105 |
| 2020 11 | 49 | 30 | 79 |
| 2020 10 | 46 | 29 | 75 |
| 2020 9 | 48 | 20 | 68 |
| 2020 8 | 35 | 20 | 55 |
| 2020 7 | 66 | 25 | 91 |
| 2020 6 | 65 | 23 | 88 |
| 2020 5 | 36 | 17 | 53 |
| 2020 4 | 62 | 28 | 90 |
| 2020 3 | 43 | 19 | 62 |
| 2020 2 | 74 | 32 | 106 |
| 2020 1 | 48 | 12 | 60 |
| 2019 12 | 66 | 35 | 101 |
| 2019 11 | 33 | 8 | 41 |
| 2019 10 | 81 | 23 | 104 |
| 2019 9 | 79 | 17 | 96 |
| 2019 8 | 83 | 14 | 97 |
| 2019 7 | 87 | 16 | 103 |
| 2019 6 | 86 | 27 | 113 |
| 2019 5 | 62 | 76 | 138 |
| 2019 4 | 284 | 17 | 301 |
| 2019 3 | 38 | 18 | 56 |
| 2019 2 | 40 | 20 | 60 |
| 2019 1 | 31 | 22 | 53 |
| 2018 12 | 42 | 17 | 59 |
| 2018 11 | 87 | 30 | 117 |
| 2018 10 | 102 | 32 | 134 |
| 2018 9 | 193 | 31 | 224 |
| 2018 8 | 186 | 9 | 195 |
| 2018 7 | 139 | 15 | 154 |
| 2018 6 | 160 | 24 | 184 |
| 2018 5 | 243 | 24 | 267 |
| 2018 4 | 321 | 11 | 332 |
| 2018 3 | 315 | 11 | 326 |
| 2018 2 | 81 | 12 | 93 |
| 2018 1 | 39 | 5 | 44 |
| 2017 12 | 47 | 14 | 61 |
| 2017 11 | 57 | 11 | 68 |
| 2017 10 | 68 | 13 | 81 |
| 2017 9 | 53 | 14 | 67 |
| 2017 8 | 41 | 23 | 64 |
| 2017 7 | 54 | 23 | 77 |
| 2017 6 | 62 | 27 | 89 |
| 2017 5 | 77 | 31 | 108 |
| 2017 4 | 61 | 25 | 86 |
| 2017 3 | 76 | 40 | 116 |
| 2017 2 | 135 | 36 | 171 |
| 2017 1 | 69 | 38 | 107 |
| 2016 12 | 78 | 21 | 99 |
| 2016 11 | 117 | 27 | 144 |
| 2016 10 | 138 | 30 | 168 |
| 2016 9 | 517 | 26 | 543 |
| 2016 8 | 172 | 16 | 188 |
| 2016 7 | 91 | 12 | 103 |
Show all
